Semaglutide is genuinely expensive, and most people are not going to pay $1,300 a month for Ozempic out of pocket. So they look for options, and a clear pattern of names shows up repeatedly in forums, subreddits, and patient Facebook groups.
Not all of them are equal. The 2026 market got complicated fast. A settlement between Novo Nordisk and several major telehealth players, finalized March 9, pushed a number of big platforms away from compounded versions entirely, and the FDA issued warning letters to more than 30 compounders over how they marketed their GLP-1 products. Some brands adapted by shifting patients to branded Wegovy and Ozempic. Others held the line on compounding, leaning harder into transparency to justify the choice.
Here are the eight names that keep surfacing, and the reasons people gravitate toward each.
1. Mochi Health
The one name that shows up more than any other when people ask for affordable semaglutide with real clinical oversight. Compounded semaglutide runs around $99 a month, compounded tirzepatide around $199, with steeper discounts for 3 or 12-month commitments. What separates Mochi from pure cost-cutters is that their clinicians are board-certified in obesity medicine specifically, not just general telehealth prescribers. That matters for dosing conversations. They also accept insurance for branded meds when patients qualify.
2. FormBlends
This one shows up in peptide and biohacking communities specifically, but it is increasingly recommended in weight-loss spaces too, for a specific reason. Where most GLP-1 telehealth brands handle one category and nothing else, FormBlends runs a wide catalog of compounded products through a single compounding pharmacy partner, all under physician supervision, covering GLP-1s alongside peptides for recovery, cognition, and longevity. Semaglutide is priced at $299 per vial, tirzepatide at $349. No membership layered on top. You see what you pay before you commit to anything.
Available in 47 states, with cold-chain shipping included. The intake is online, a licensed prescriber reviews and approves, and it goes out from there. For someone already interested in, say, BPC-157 ($54) or NAD+ ($89) alongside a weight management protocol, having one clinical relationship covering all of it is genuinely more efficient than juggling three separate platforms. Compounded medications are not FDA-approved products, which is true here as it is everywhere in this category, and worth keeping in mind.
3. Henry Meds
Fast. People mention shipping times constantly with Henry Meds, often 24 to 72 hours from approval to delivery. Cash-pay compounded programs in the $179 to $249 range for month one. The tradeoff is that the ongoing clinical monitoring is lighter than what you get from a more hands-on program. Fine for people who are self-directed and just want the medication moving.
4. Eden
Compounded semaglutide around $149 a month, cash pay, no frills. Eden does not try to be a wellness ecosystem. It comes up when people are specifically asking “what is the cheapest credible option” and want a direct answer.
5. Ro Body
Ro’s membership structure starts around $39 for the first month, with medication billed separately. On an annual prepay, the membership side drops to roughly $74 a month. They have built a prior-authorization team specifically to help patients get branded meds covered by insurance, which is a real differentiator for anyone sitting on decent employer coverage. Polished product. Established company.
6. Hims and Hers
After the Novo settlement took effect, Hims and Hers moved new patients onto branded products. Injectable Wegovy runs around $299 a month through their platform, oral Wegovy around $249. With commercial insurance plus a savings card, branded pricing can reportedly drop to near zero. Slick app, fast onboarding, and strong name recognition bring people in. Not the most affordable cash-pay option anymore, but competitive for insured patients.
7. MEDVi
Around $179 for the first month, no contracts, no recurring membership fee, with physician review included and 24/7 support access. MEDVi does not dominate the conversation the way Mochi or Ro does, but it comes up consistently when people compare compounded options specifically on cost and simplicity. No commitments is a real draw for people who are uncertain about the first few months.
8. Sesame (Success by Sesame)
Starting around $59 a month on an annual plan, this covers telehealth visits and unlimited messaging, with medication billed separately. Sesame operates more like a marketplace than a dedicated weight-loss platform, which means pricing flexibility and the ability to shop around. For people who already know what they want and just need a prescriber in the loop, it is one of the lowest-friction entry points on this list.
The market in 2026 is noisier than it was two years ago, with more scrutiny on how compounding pharmacies advertise and what claims they make. That is not a reason to avoid compounded semaglutide categorically, but it is a reason to choose a provider that is transparent about what the medication is, where it comes from, and what oversight exists. The options above, whatever their differences, all have that baseline.
Before starting any GLP-1 protocol, run the plan by someone who can actually look at your full health picture, not just a quick intake form. That step matters more than the monthly price.
Sources
- FDA.gov (warning letters to compounding facilities, GLP-1 shortage status updates)
- Drugs.com (branded semaglutide pricing and coverage data)
- GoodRx (Ozempic, Wegovy cash pricing benchmarks)
- Examine.com (semaglutide pharmacology and evidence summaries)
- Cleveland Clinic (GLP-1 receptor agonist overview)
- Verywell Health (telehealth weight-loss platform comparisons)
- Healthline (compounded semaglutide explainer, 2024-2025)
- NEJM (semaglutide clinical trials, STEP program)
[internal: placement 2nd or 3rd | structure: Social-proof framing, quotes/themes]
